Annotation Detail for CRYBB2
Basic Information
Top
Desease ID | Desease Name |
---|
1808 | Eye disease |
Desease Name |
---|
Cataract, sutural, with punctate and cerulean opacities |
Cataract, Coppock-like |
Cataract, cerulean, type 2 |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D019386 |
Alendronate |
Alendronate affects the expression of CRYBB2 mRNA | affects expression | 16079270
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of CRYBB2 mRNA | affects expression | 16079270
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of CRYBB2 mRNA | increases expression | 18035473
|
C025299 |
polyphenols |
polyphenols results in decreased expression of CRYBB2 mRNA | decreases expression | 16293270
|
D020849 |
Raloxifene |
Raloxifene affects the expression of CRYBB2 mRNA | affects expression | 16079270
|
D014501 |
Uranium |
Uranium affects the expression of CRYBB2 mRNA | affects expression | 15672453
|
C005460 |
uranyl acetate |
uranyl acetate affects the expression of CRYBB2 mRNA | affects expression | 15672453
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.38 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.86 | 14692618 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.92 | 17451421 17308373 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.59 | 15800139 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.82 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.82 | 15885639 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.83 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.64 | 17242785 17440819 17595753 17049068 16837676 17261762 15572757 17952589 16912660 17893378 15758505 15775269 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.34 | 17572228 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.63 | 15775269 |
MESH:D002386 |
Cataract |
marker/mechanism |
|
| |
OMIM:601547 |
CATARACT, CONGENITAL, CERULEAN TYPE, 2 |
marker/mechanism |
|
| |
OMIM:604307 |
CATARACT, COPPOCK-LIKE |
marker/mechanism |
|
| |
OMIM:607133 |
CATARACT, SUTURAL, WITH PUNCTATE AND CERULEAN OPACITIES |
marker/mechanism |
|
| |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.07 | 17110522 17681005 17333356 15861022 16919318 11677210 16105132 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.98 | 15800139 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
2.71 | 16293270 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.41 | 17474826 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
4.18 | 17451421 15920148 17308373 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
2.80 | 19370779 |
MESH:D004487 |
Edema |
|
Raloxifene |
3.61 | 15860553 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
10.23 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
10.23 | 15845917 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
8.81 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
8.81 | 17473493 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.72 | 11110106 |
MESH:D006930 |
Hyperalgesia |
|
Alendronate |
4.93 | 16769263 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
2.95 | 15787275 17577099 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.17 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.77 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.66 | 17937319 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
5.87 | 17296493 |
MESH:D007249 |
Inflammation |
|
polyphenols |
5.87 | 16366677 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.80 | 16973256 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
2.83 | 16698588 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
6.00 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.63 | 16497877 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
6.00 | 16343187 |
MESH:D010024 |
Osteoporosis |
|
Alendronate |
8.32 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
8.32 | 19059307 15775268 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.53 | 15579764 17823083 15758505 17893378 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.99 | 11578682 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
3.56 | 16536755 15731164 16220300 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.71 | 15861022 16919318 |
MESH:D011693 |
Purpura |
|
Raloxifene |
6.00 | 15770314 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.38 | 16709447 |
MESH:D020521 |
Stroke |
|
Raloxifene |
4.04 | 16837676 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.69 | 17997062 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.92 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.40 | 15669648 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.65 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
2.90 | 17572228 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.63 | 14692618 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.65 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.82 | 14671159 15869587 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
6.00 | 16343187 |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB03131 |
- |
Beta-Mercaptoethanol |
|